Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren J Porter

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
JEMS : a Journal of Emergency Medical Services|December 16, 2004
Poor CPR shownWarren J Porter
Emergency Medical Services|June 26, 2004
Accepting complaintsWarren J Porter
Emergency Medical Services|January 27, 2006
EMS: it's about customer serviceWarren J Porter
Emergency Medical Services|June 26, 2004
Everyday EMS leadershipWarren J Porter
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Discovery and SAR studies of novel GlyT1 inhibitorsMagnus W Walter, Beth J Hoffman, Kimberly Gordon, et al.
CNS & Neurological Disorders Drug Targets|November 2, 2017
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)Jeffrey M Witkin, Douglas A Schober, Scott D Gleason, et al.
Neuropharmacology|August 1, 2017
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptorsJeffrey M Witkin, Jennifer Li, Gary Gilmour, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
The development of potent and selective bisarylmaleimide GSK3 inhibitorsThomas A Engler, Sushant Malhotra, Timothy P Burkholder, et al.
Neuropharmacology|July 8, 2008
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areasKenneth W Perry, Julie F Falcone, Matthew J Fell, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
JEMS : a Journal of Emergency Medical Services|December 16, 2004
Poor CPR shownWarren J Porter
Emergency Medical Services|June 26, 2004
Accepting complaintsWarren J Porter
Emergency Medical Services|January 27, 2006
EMS: it's about customer serviceWarren J Porter
Emergency Medical Services|June 26, 2004
Everyday EMS leadershipWarren J Porter
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Discovery and SAR studies of novel GlyT1 inhibitorsMagnus W Walter, Beth J Hoffman, Kimberly Gordon, et al.
CNS & Neurological Disorders Drug Targets|November 2, 2017
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)Jeffrey M Witkin, Douglas A Schober, Scott D Gleason, et al.
Neuropharmacology|August 1, 2017
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptorsJeffrey M Witkin, Jennifer Li, Gary Gilmour, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
The development of potent and selective bisarylmaleimide GSK3 inhibitorsThomas A Engler, Sushant Malhotra, Timothy P Burkholder, et al.
Neuropharmacology|July 8, 2008
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areasKenneth W Perry, Julie F Falcone, Matthew J Fell, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Pageof 2